Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for LXRX

Stock Name	Lexicon Pharmaceuticals Inc
Ticker	LXRX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US5288723027

Show aggregate LXRX holdings

News associated with LXRX

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Given Average Rating of “Hold” by Analysts: Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) have earned a consensus rating of “Hold” from the five analysts that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year target price […] - 2025-07-10 05:48:56
HC Wainwright Reaffirms “Buy” Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX): Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $4.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s target price would indicate a potential upside of 344.44% from the stock’s current price. […] - 2025-06-26 02:48:53
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Crosses Above 200 Day Moving Average – Here’s What Happened: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.65 and traded as high as $0.75. Lexicon Pharmaceuticals shares last traded at $0.73, with a volume of 2,479,330 shares changing hands. Analyst Upgrades and Downgrades […] - 2025-06-24 05:14:58
Hennion & Walsh Asset Management Inc. Sells 33,201 Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX): Hennion & Walsh Asset Management Inc. lessened its position in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 3.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 830,054 shares of the biopharmaceutical company’s stock after selling 33,201 shares […] - 2025-06-09 05:32:51
Deutsche Bank AG Boosts Holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX): Deutsche Bank AG increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 378.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 315,659 shares of the biopharmaceutical company’s stock after acquiring an additional 249,616 shares during the quarter. Deutsche Bank AG’s holdings in Lexicon Pharmaceuticals were worth $234,000 as of […] - 2025-06-02 04:52:49
Woodline Partners LP Lowers Stock Holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX): Woodline Partners LP cut its stake in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 81.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 229,376 shares of the biopharmaceutical company’s stock after selling 982,548 shares during the quarter. Woodline Partners […] - 2025-05-28 05:25:05
Contrasting Lexicon Pharmaceuticals (NASDAQ:LXRX) & Grifols (NASDAQ:GRFS): Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) and Grifols (NASDAQ:GRFS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership. Profitability This table compares Lexicon Pharmaceuticals and Grifols’ net […] - 2025-05-26 02:20:56
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Stake Boosted by Invesco Ltd.: Invesco Ltd. grew its holdings in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 60.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 104,494 shares of the biopharmaceutical company’s stock after purchasing an additional 39,420 shares during the quarter. Invesco Ltd.’s […] - 2025-05-06 04:28:46
Lexicon Pharmaceuticals (NASDAQ:LXRX) Coverage Initiated by Analysts at StockNews.com: StockNews.com initiated coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on the company. Needham & Company LLC reissued a “hold” […] - 2025-04-21 03:10:46
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives $3.67 Consensus PT from Analysts: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has been given a consensus recommendation of “Hold” by the five brokerages that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective […] - 2025-04-04 02:12:45
Virtu Financial LLC Invests $66,000 in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX): Virtu Financial LLC purchased a new stake in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 88,982 shares of the biopharmaceutical company’s stock, valued at approximately $66,000. Other hedge funds and other […] - 2025-04-01 04:56:52
Swiss National Bank Grows Stock Holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX): Swiss National Bank increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 34.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 426,600 shares of the biopharmaceutical company’s stock after buying an additional 109,100 shares during the quarter. Swiss National Bank’s holdings in Lexicon Pharmaceuticals were worth $315,000 as of its […] - 2025-03-31 04:50:50
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of “Hold” from Analysts: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has received a consensus rating of “Hold” from the five ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokerages […] - 2025-03-12 04:52:43
Lexicon Pharmaceuticals (NASDAQ:LXRX) Coverage Initiated by Analysts at StockNews.com: Equities research analysts at StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on the company. Piper Sandler cut their target price on […] - 2025-03-12 04:19:02
Piper Sandler Issues Pessimistic Forecast for Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price: Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) had its price objective lowered by Piper Sandler from $10.00 to $6.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has an overweight rating on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on LXRX. Leerink Partners reissued a “market perform” rating […] - 2025-03-10 04:58:47
Lexicon Pharmaceuticals (NASDAQ:LXRX) Rating Lowered to Hold at Leerink Partnrs: Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was downgraded by Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Other analysts have also recently issued reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Lexicon Pharmaceuticals […] - 2025-03-07 06:28:46

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) LXRX holdings

Date	Number of LXRX Shares Held	Base Market Value of LXRX Shares	Local Market Value of LXRX Shares	Change in LXRX Shares Held	Change in LXRX Base Value	Current Price per LXRX Share Held	Previous Price per LXRX Share Held
2025-12-18 (Thursday)	274,688	USD 324,132	USD 324,132	0	USD 8,241	USD 1.18	USD 1.15
2025-12-17 (Wednesday)	274,688	USD 315,891	USD 315,891	-3,255	USD -17,641	USD 1.15	USD 1.2
2025-12-16 (Tuesday)	277,943	USD 333,532	USD 333,532	-651	USD -9,139	USD 1.2	USD 1.23
2025-12-15 (Monday)	278,594	USD 342,671	USD 342,671	1,300	USD -17,811	USD 1.23	USD 1.3
2025-12-12 (Friday)	277,294	USD 360,482	USD 360,482	0	USD -5,546	USD 1.3	USD 1.32
2025-12-11 (Thursday)	277,294	USD 366,028	USD 366,028	1,312	USD 1,732	USD 1.32	USD 1.32
2025-12-10 (Wednesday)	275,982	USD 364,296	USD 364,296	0	USD 2,760	USD 1.32	USD 1.31

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LXRX by Blackrock for IE00BDZVHG35

Show aggregate share trades of LXRX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-17 SELL -3,255 1.220 1.140 1.148 USD -3,737 0.96 Loss of -606 on sale
2025-12-16 SELL -651 1.250 1.170 1.178 USD -767 0.96 Loss of -141 on sale
2025-12-15 BUY 1,300 1.330 1.230 1.240 USD 1,612 0.96
2025-12-11 BUY 1,312 1.360 1.300 1.306 USD 1,714 0.96
2025-12-04 BUY 12,760 1.430 1.380 1.385 USD 17,673 0.95
2025-12-02 BUY 9,645 1.395 1.340 1.346 USD 12,977 0.95
2025-11-28 BUY 642 1.470 1.400 1.407 USD 903 0.94
2025-11-26 BUY 1,926 1.440 1.390 1.395 USD 2,687 0.94
2025-11-26 BUY 1,926 1.440 1.390 1.395 USD 2,687 0.94
2025-11-25 BUY 3,210 1.440 1.370 1.377 USD 4,420 0.94
2025-11-24 BUY 645 1.420 1.340 1.348 USD 869 0.94
2025-11-20 SELL -2,544 1.510 1.320 1.339 USD -3,406 0.93 Loss of -1,036 on sale
2025-11-19 BUY 635 1.520 1.425 1.434 USD 911 0.93
2025-11-18 BUY 3,810 1.480 1.430 1.435 USD 5,467 0.93
2025-11-17 BUY 1,270 1.470 1.420 1.425 USD 1,810 0.93
2025-11-14 BUY 636 1.505 1.360 1.375 USD 874 0.92
2025-11-12 BUY 635 1.640 1.470 1.487 USD 944 0.92
2025-11-10 BUY 634 1.450 1.250 1.270 USD 805 0.91
2025-11-06 BUY 633 1.525 1.390 1.404 USD 888 0.91
2025-11-04 BUY 637 1.390 1.325 1.332 USD 848 0.91
2025-10-30 BUY 3,190 1.370 1.303 1.310 USD 4,178 0.90
2025-10-29 BUY 1,274 1.330 1.370 1.366 USD 1,740 0.90
2025-10-22 SELL -2,524 1.390 1.450 1.444 USD -3,645 0.89 Loss of -1,403 on sale
2025-10-20 BUY 1,262 1.520 1.530 1.529 USD 1,930 0.88
2025-10-17 BUY 3,149 1.420 1.460 1.456 USD 4,585 0.88
2025-10-15 BUY 5,000 1.530 1.530 1.530 USD 7,650 0.88
2025-10-09 BUY 7,148 1.640 1.650 1.649 USD 11,787 0.87
2025-10-06 BUY 1,923 1.550 1.550 1.550 USD 2,981 0.86
2025-10-03 BUY 4,466 1.410 1.460 1.455 USD 6,498 0.86
2025-10-02 BUY 638 1.380 1.450 1.443 USD 921 0.86
2025-09-30 BUY 1,274 1.350 1.390 1.386 USD 1,766 0.85
2025-09-26 BUY 1,276 1.400 1.420 1.418 USD 1,809 0.85
2025-09-25 BUY 1,278 1.340 1.370 1.367 USD 1,747 0.85
2025-09-18 BUY 648 1.220 1.250 1.247 USD 808 0.84
2025-09-17 BUY 1,953 1.090 1.110 1.108 USD 2,164 0.84
2025-09-11 SELL -646 1.110 1.130 1.128 USD -729 0.84 Loss of -189 on sale
2025-09-10 BUY 1,292 1.080 1.130 1.125 USD 1,454 0.83
2025-09-05 SELL -644 1.090 1.110 1.108 USD -714 0.83 Loss of -179 on sale
2025-08-29 SELL -1,938 1.100 1.150 1.145 USD -2,219 0.82 Loss of -621 on sale
2025-08-27 BUY 1,284 1.130 1.150 1.148 USD 1,474 0.82
2025-08-26 SELL -641 1.140 1.160 1.158 USD -742 0.82 Loss of -217 on sale
2025-08-25 BUY 642 1.130 1.200 1.193 USD 766 0.82
2025-08-20 SELL -2,548 1.130 1.160 1.157 USD -2,948 0.81 Loss of -872 on sale
2025-08-18 BUY 1,268 1.210 1.240 1.237 USD 1,569 0.81
2025-08-08 SELL -1,268 1.080 1.150 1.143 USD -1,449 0.80 Loss of -431 on sale
2025-08-05 BUY 632 1.050 1.140 1.131 USD 715 0.80
2025-08-01 SELL -1,891 1.070 1.100 1.097 USD -2,074 0.79 Loss of -571 on sale
2025-07-30 BUY 2,520 1.020 1.100 1.092 USD 2,752 0.79
2025-07-17 SELL -1,260 1.350 1.430 1.422 USD -1,792 0.77 Loss of -820 on sale
2025-07-11 SELL -5,112 1.080 1.130 1.125 USD -5,751 0.76 Loss of -1,857 on sale
2025-07-07 BUY 1,926 0.870 0.910 0.906 USD 1,745 0.76
2025-07-02 BUY 35,365 0.920 0.930 0.929 USD 32,854 0.75
2025-06-25 BUY 1,286 0.900 0.920 0.918 USD 1,181 0.75
2025-06-11 BUY 1,292 0.700 0.730 0.727 USD 939 0.75
2025-06-10 BUY 1,292 0.700 0.740 0.736 USD 951 0.75
2025-06-04 SELL -646 0.660 0.700 0.696 USD -450 0.75 Profit of 36 on sale
2025-04-23 BUY 646 0.670 0.690 0.688 USD 444 0.78
2025-04-10 SELL -5,168 0.500 0.540 0.536 USD -2,770 0.80 Profit of 1,376 on sale
2025-04-08 SELL -1,294 0.500 0.590 0.581 USD -752 0.81 Profit of 295 on sale
2025-04-04 SELL -3,235 0.420 0.460 0.456 USD -1,475 0.82 Profit of 1,164 on sale
2025-04-01 BUY 2,588 0.460 0.540 0.532 USD 1,377 0.82
2025-03-31 SELL -1,941 0.460 0.710 0.685 USD -1,330 0.83 Profit of 275 on sale
2025-03-14 SELL -10,384 0.370 0.370 0.370 USD -3,842 0.89 Profit of 5,368 on sale
2025-03-07 SELL -1,298 0.390 0.410 0.408 USD -530 0.92 Profit of 665 on sale
2025-03-04 SELL -649 0.320 0.340 0.338 USD -219 0.94 Profit of 393 on sale
2025-02-25 BUY 1,298 0.660 0.710 0.705 USD 915 0.97
2025-02-19 SELL -649 0.740 0.790 0.785 USD -509 0.98 Profit of 129 on sale
2025-02-13 BUY 1,947 0.740 0.750 0.749 USD 1,458 1.00
2025-02-12 BUY 649 0.700 0.720 0.718 USD 466 1.00
2025-02-11 BUY 2,592 0.700 0.750 0.745 USD 1,931 1.01
2025-01-17 BUY 2,592 0.690 0.720 0.717 USD 1,858 1.09
2025-01-16 BUY 2,588 0.710 0.730 0.728 USD 1,884 1.10
2025-01-10 SELL -1,296 0.770 0.860 0.851 USD -1,103 1.14 Profit of 378 on sale
2025-01-08 SELL -2,592 0.860 0.910 0.905 USD -2,346 1.16 Profit of 658 on sale
2024-12-30 SELL -3,240 0.720 0.770 0.765 USD -2,479 1.18 Profit of 1,357 on sale
2024-11-18 SELL -9,618 0.910 1.000 0.991 USD -9,531 1.61 Profit of 5,957 on sale
2024-11-08 SELL -637 1.270 1.320 1.315 USD -838 1.66 Profit of 223 on sale
2024-10-21 SELL -637 1.950 2.080 2.067 USD -1,317 0.00 Loss of -1,317 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-17	SELL	-3,255	1.220	1.140	1.148	USD -3,737	0.96 Loss of -606 on sale
2025-12-16	SELL	-651	1.250	1.170	1.178	USD -767	0.96 Loss of -141 on sale
2025-12-15	BUY	1,300	1.330	1.230	1.240	USD 1,612	0.96
2025-12-11	BUY	1,312	1.360	1.300	1.306	USD 1,714	0.96
2025-12-04	BUY	12,760	1.430	1.380	1.385	USD 17,673	0.95
2025-12-02	BUY	9,645	1.395	1.340	1.346	USD 12,977	0.95
2025-11-28	BUY	642	1.470	1.400	1.407	USD 903	0.94
2025-11-26	BUY	1,926	1.440	1.390	1.395	USD 2,687	0.94
2025-11-26	BUY	1,926	1.440	1.390	1.395	USD 2,687	0.94
2025-11-25	BUY	3,210	1.440	1.370	1.377	USD 4,420	0.94
2025-11-24	BUY	645	1.420	1.340	1.348	USD 869	0.94
2025-11-20	SELL	-2,544	1.510	1.320	1.339	USD -3,406	0.93 Loss of -1,036 on sale
2025-11-19	BUY	635	1.520	1.425	1.434	USD 911	0.93
2025-11-18	BUY	3,810	1.480	1.430	1.435	USD 5,467	0.93
2025-11-17	BUY	1,270	1.470	1.420	1.425	USD 1,810	0.93
2025-11-14	BUY	636	1.505	1.360	1.375	USD 874	0.92
2025-11-12	BUY	635	1.640	1.470	1.487	USD 944	0.92
2025-11-10	BUY	634	1.450	1.250	1.270	USD 805	0.91
2025-11-06	BUY	633	1.525	1.390	1.404	USD 888	0.91
2025-11-04	BUY	637	1.390	1.325	1.332	USD 848	0.91
2025-10-30	BUY	3,190	1.370	1.303	1.310	USD 4,178	0.90
2025-10-29	BUY	1,274	1.330	1.370	1.366	USD 1,740	0.90
2025-10-22	SELL	-2,524	1.390	1.450	1.444	USD -3,645	0.89 Loss of -1,403 on sale
2025-10-20	BUY	1,262	1.520	1.530	1.529	USD 1,930	0.88
2025-10-17	BUY	3,149	1.420	1.460	1.456	USD 4,585	0.88
2025-10-15	BUY	5,000	1.530	1.530	1.530	USD 7,650	0.88
2025-10-09	BUY	7,148	1.640	1.650	1.649	USD 11,787	0.87
2025-10-06	BUY	1,923	1.550	1.550	1.550	USD 2,981	0.86
2025-10-03	BUY	4,466	1.410	1.460	1.455	USD 6,498	0.86
2025-10-02	BUY	638	1.380	1.450	1.443	USD 921	0.86
2025-09-30	BUY	1,274	1.350	1.390	1.386	USD 1,766	0.85
2025-09-26	BUY	1,276	1.400	1.420	1.418	USD 1,809	0.85
2025-09-25	BUY	1,278	1.340	1.370	1.367	USD 1,747	0.85
2025-09-18	BUY	648	1.220	1.250	1.247	USD 808	0.84
2025-09-17	BUY	1,953	1.090	1.110	1.108	USD 2,164	0.84
2025-09-11	SELL	-646	1.110	1.130	1.128	USD -729	0.84 Loss of -189 on sale
2025-09-10	BUY	1,292	1.080	1.130	1.125	USD 1,454	0.83
2025-09-05	SELL	-644	1.090	1.110	1.108	USD -714	0.83 Loss of -179 on sale
2025-08-29	SELL	-1,938	1.100	1.150	1.145	USD -2,219	0.82 Loss of -621 on sale
2025-08-27	BUY	1,284	1.130	1.150	1.148	USD 1,474	0.82
2025-08-26	SELL	-641	1.140	1.160	1.158	USD -742	0.82 Loss of -217 on sale
2025-08-25	BUY	642	1.130	1.200	1.193	USD 766	0.82
2025-08-20	SELL	-2,548	1.130	1.160	1.157	USD -2,948	0.81 Loss of -872 on sale
2025-08-18	BUY	1,268	1.210	1.240	1.237	USD 1,569	0.81
2025-08-08	SELL	-1,268	1.080	1.150	1.143	USD -1,449	0.80 Loss of -431 on sale
2025-08-05	BUY	632	1.050	1.140	1.131	USD 715	0.80
2025-08-01	SELL	-1,891	1.070	1.100	1.097	USD -2,074	0.79 Loss of -571 on sale
2025-07-30	BUY	2,520	1.020	1.100	1.092	USD 2,752	0.79
2025-07-17	SELL	-1,260	1.350	1.430	1.422	USD -1,792	0.77 Loss of -820 on sale
2025-07-11	SELL	-5,112	1.080	1.130	1.125	USD -5,751	0.76 Loss of -1,857 on sale
2025-07-07	BUY	1,926	0.870	0.910	0.906	USD 1,745	0.76
2025-07-02	BUY	35,365	0.920	0.930	0.929	USD 32,854	0.75
2025-06-25	BUY	1,286	0.900	0.920	0.918	USD 1,181	0.75
2025-06-11	BUY	1,292	0.700	0.730	0.727	USD 939	0.75
2025-06-10	BUY	1,292	0.700	0.740	0.736	USD 951	0.75
2025-06-04	SELL	-646	0.660	0.700	0.696	USD -450	0.75 Profit of 36 on sale
2025-04-23	BUY	646	0.670	0.690	0.688	USD 444	0.78
2025-04-10	SELL	-5,168	0.500	0.540	0.536	USD -2,770	0.80 Profit of 1,376 on sale
2025-04-08	SELL	-1,294	0.500	0.590	0.581	USD -752	0.81 Profit of 295 on sale
2025-04-04	SELL	-3,235	0.420	0.460	0.456	USD -1,475	0.82 Profit of 1,164 on sale
2025-04-01	BUY	2,588	0.460	0.540	0.532	USD 1,377	0.82
2025-03-31	SELL	-1,941	0.460	0.710	0.685	USD -1,330	0.83 Profit of 275 on sale
2025-03-14	SELL	-10,384	0.370	0.370	0.370	USD -3,842	0.89 Profit of 5,368 on sale
2025-03-07	SELL	-1,298	0.390	0.410	0.408	USD -530	0.92 Profit of 665 on sale
2025-03-04	SELL	-649	0.320	0.340	0.338	USD -219	0.94 Profit of 393 on sale
2025-02-25	BUY	1,298	0.660	0.710	0.705	USD 915	0.97
2025-02-19	SELL	-649	0.740	0.790	0.785	USD -509	0.98 Profit of 129 on sale
2025-02-13	BUY	1,947	0.740	0.750	0.749	USD 1,458	1.00
2025-02-12	BUY	649	0.700	0.720	0.718	USD 466	1.00
2025-02-11	BUY	2,592	0.700	0.750	0.745	USD 1,931	1.01
2025-01-17	BUY	2,592	0.690	0.720	0.717	USD 1,858	1.09
2025-01-16	BUY	2,588	0.710	0.730	0.728	USD 1,884	1.10
2025-01-10	SELL	-1,296	0.770	0.860	0.851	USD -1,103	1.14 Profit of 378 on sale
2025-01-08	SELL	-2,592	0.860	0.910	0.905	USD -2,346	1.16 Profit of 658 on sale
2024-12-30	SELL	-3,240	0.720	0.770	0.765	USD -2,479	1.18 Profit of 1,357 on sale
2024-11-18	SELL	-9,618	0.910	1.000	0.991	USD -9,531	1.61 Profit of 5,957 on sale
2024-11-08	SELL	-637	1.270	1.320	1.315	USD -838	1.66 Profit of 223 on sale
2024-10-21	SELL	-637	1.950	2.080	2.067	USD -1,317	0.00 Loss of -1,317 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LXRX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	552,694	9,926	1,527,473	36.2%
2025-09-18	592,356	26,469	2,644,149	22.4%
2025-09-17	333,839	1,486	1,112,518	30.0%
2025-09-16	162,349	1,000	648,238	25.0%
2025-09-15	298,403	0	729,451	40.9%
2025-09-12	194,067	0	839,303	23.1%
2025-09-11	264,191	0	844,984	31.3%
2025-09-10	395,398	31,133	985,195	40.1%
2025-09-09	328,166	0	1,032,168	31.8%
2025-09-08	223,541	0	677,316	33.0%
2025-09-05	328,016	6,730	952,524	34.4%
2025-09-04	548,127	3,201	1,021,498	53.7%
2025-09-03	295,333	262	637,100	46.4%
2025-09-02	538,506	14,402	1,762,219	30.6%
2025-08-29	345,884	2,234	859,802	40.2%
2025-08-28	728,292	68,203	1,114,236	65.4%
2025-08-27	310,746	2,689	726,712	42.8%
2025-08-26	154,195	1,435	477,693	32.3%
2025-08-25	240,938	10	729,455	33.0%
2025-08-22	356,761	16,225	894,165	39.9%
2025-08-21	221,518	0	930,553	23.8%
2025-08-20	354,653	679	900,661	39.4%
2025-08-19	546,688	787	996,668	54.9%
2025-08-18	266,621	8,030	1,107,436	24.1%
2025-08-15	647,841	0	1,703,210	38.0%
2025-08-14	604,639	1,500	1,833,827	33.0%
2025-08-13	478,070	657	1,433,369	33.4%
2025-08-12	414,053	1,300	1,210,445	34.2%
2025-08-11	638,449	0	1,255,077	50.9%
2025-08-08	381,262	200	1,766,493	21.6%
2025-08-07	866,649	3,935	1,504,686	57.6%
2025-08-06	1,447,669	23,706	3,328,026	43.5%
2025-08-05	1,235,280	27,251	1,934,354	63.9%
2025-08-04	556,747	2,956	1,279,321	43.5%
2025-08-01	251,250	130	613,464	41.0%
2025-07-31	588,667	1,120	1,252,380	47.0%
2025-07-30	487,718	2,682	984,839	49.5%
2025-07-29	509,454	6,800	1,082,024	47.1%
2025-07-28	1,021,814	2,400	1,931,041	52.9%
2025-07-25	578,656	3,410	1,498,497	38.6%
2025-07-24	509,913	10,838	1,778,665	28.7%
2025-07-23	586,378	0	1,473,386	39.8%
2025-07-22	787,437	71,489	2,453,028	32.1%
2025-07-21	1,378,016	111,261	2,150,151	64.1%
2025-07-18	1,802,764	121,431	3,428,408	52.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE